The contribution of in vitro toxicity data in hazard and risk assessment: Current limitations and future perspectives

Toxicology Letters

Volumn 180, Issue 2, 2008, Pages 81-84

  Blaauboer, Bas J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

In vitro methods; Integrated strategies; Toxicological risk assessment

Indexed keywords

BIOLOGICAL MARKER; LACTATE DEHYDROGENASE;

ARTICLE; BIOLOGY; CANCER RISK; CELL AGGREGATION; CELL CULTURE; CELL DEATH; CELL LINE; COCULTURE; CULTURE MEDIUM; CYTOLOGY; CYTOTOXICITY; ELECTROPHYSIOLOGY; ENERGY TRANSFER; FLOW CYTOMETRY; GENOMICS; GENOTOXICITY; HAZARD ASSESSMENT; HUMAN; IN VITRO STUDY; KINETICS; MICROSCOPY; NEUROTOXICITY; NONHUMAN; PHOTOTOXICITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION; TISSUE SLICE; TOXICITY TESTING; TOXICOLOGY; TRANSCRIPTOMICS;

ANIMALS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; RISK ASSESSMENT; TOXICITY TESTS; TOXICOLOGY;

EID: 48649099822     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.05.008     Document Type: Article

References (39)

1. Andersen M.E. Physiological modelling of organic compounds. Ann. Occup. Hyg. 35 (1991) 309-321
2. Barratt M.D. The role of structure-activity relationships and expert systems in alternative strategies for the determination of skin sensitisation, skin corrosivity and eye irritation. Altern. Lab. Anim. 23 (1995) 111-122
3. Blaauboer B.J. Biokinetic and toxicodynamic modelling and its role in toxicological research and risk assessment. Altern. Lab. Anim. 31 (2003) 277-281
4. Blaauboer B.J., and Andersen M.E. The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testin initiative. Letter to the Editor. Arch. Toxicol. 81 (2007) 385-387
5. Blaauboer B.J., Balls M., Barratt M., Casati S., Coecke S., Mohamed M.K., Moore J., Rall D., Smith K.R., Tennant R., Schwetz B.A., Stokes W.S., and Younes M. 13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies and conceptual issues. Environ. Health Perspect. 106 (1998) 413-415
6. Blaauboer B.J., Barratt M.D., and Houston J.B. The integrated use of alternative methods in toxicological risk evaluation. ECVAM integrated testing strategies task force report 1. Altern. Lab. Anim. 27 (1999) 229-237
7. 1
8. Combes R., Barratt M., and Balls M. An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH System. Altern. Lab. Anim. 31 (2003) 7-19
9. Combrier E., Métézeau P., Ronot X., Gachelin H., and Adolphe M. Flow cytometric assessment of cell viability: a multifaceted analysis. Cytotechnology 2 (1989) 27-37
10. Corvi R., Ahr H.-J., Albertini S., Blakey D.H., Clerici L., Coecke S., Douglas G.R., Gribaldo L., Groten J.P., Haase B., Hamernik K., Hartung T., Inoue T., Indans I., Maurici D., Orphanides G., Rembges D., Sansone S.-A., Snape J.R., Toda E., Tong W., van Delft J.H., Weis B., and Schechtman L.M. meeting report: validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use. Environ. Health Perspect. 114 (2006) 420-429
11. DeJongh J., Nordin-Andersen M., Ploeger B.A., and Forsby A. Estimation of systemic toxicity of acrylamide by integration of in vitro data with kinetic simulations. Toxicol. Appl. Pharmacol. 158 (1999) 261-268
12. Eisenbrand G., Pool-Zobel B., Baker V., Balls M., Blaauboer B.J., Boobis A., Carere A., Kevekordes S., Lhuguenot J.-C., Pieters R., and Kleiner J. Methods of in vitro toxicology. Food Chem. Toxicol. 40 (2002) 193-236
13. Forsby A., and Blaauboer B.J. Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation. Hum. Exp. Toxicol. 26 (2007) 333-338
14. Greim H., Arand M., Autrup H., Bolt H.M., Bridges J., Dybing E., Glomot R., Foa V., and Schulte-Hermann R. Toxicological comments to the discussion about REACH. Arch. Toxicol. 80 (2006) 121-124
15. Gubbels-van Hal W.M., Blaauboer B.J., Barentsen H.M., Hoitink M.A., Meerts I.A., and van der Hoeven J.C. An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing. Regul. Toxicol. Pharmacol. 42 (2005) 284-295
16. Health Council of the Netherlands, 2001. Toxicity testing: a more efficient approach. Health Council of the Netherlands, The Hague. (www.gr.nl/references; 20 November 2001).
17. Hurni M.A., Noach A.B., Blom-Roosemalen M.C., de Boer A.G., Nagelkerke J.F., and Breimer D.D. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy. J. Pharmacol. Exp. Ther. 267 (1993) 942-950
18. Kroes R., and Feron V.J. General toxicity testing: sense and non-sense, science and policy. Fundam. Appl. Toxicol. 4 (1984) 298-308
19. Kroes R., and Feron V.J. Toxicity testing: strategies and conduct. In: Clayson D.B., Munro I.C., Shubik P., and Seenberg J.A. (Eds). Progress in Predictive Toxicology (1990), Elsevier, Amsterdam 15-39
20. Kroes R., Kleiner J., and Renwick A. The threshold of toxicological concern concept in risk assessment. Toxicol. Sci. 86 (2005) 226-230
21. Kroes R., Renwick A.G., Feron V., Galli C.L., Gibney M., Greim H., Guy R.H., Lhuguenot J.C., and van de Sandt J.J.M. Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients. Food Chem. Toxicol. 45 (2007) 2533-2562
22. LeCluyse E., Madan A., Hamilton G., Carroll K., and DeHaan R.P.A. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J. Biochem. Mol. Toxicol. 14 (2000) 177-188
23. Liebsch M., and Spielmann H. Currently available in vitro methods used in the regulatory toxicology. Toxicol. Lett. 127 (2002) 127-134
24. NAS, 2007. Toxicity testing in the 21st century. A vision and a strategy. Report of the Committee on Toxicity Testing and Assessment of Environmental Agents. National Research Council of The National Academies. The National Academies Press, Washington, DC. (www.nap.edu/catalog/11970.html).
25. Nuwaysir E.F., Bittner M., Trent J., Barrett J.C., and Afshari C.A. Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. 24 (1999) 153-159
26. OECD, 2004. OECD Guidelines for the Testing of Chemicals Test No. 432: In Vitro 3T3 NRU Phototoxicity Test.
27. Pfaller W., Balls M., Clothier R., Coecke S., Dierickx P., Ekwall B., Hanley B.A., Hartung T., Prieto P., Ryan M.P., Schmuck G., Sladowski D., Vericat J.-A., Wendel A., Wolf A., and Zimmer J. Novel advanced in vitro methods for longterm toxicity testing. The report and recommendations of ECVAM workshop 45. Altern. Lab. Anim. 29 (2001) 393-426
28. Pool-Zobel B.L., Lotzmann N., Knoll M., Kuchenmeister F., Lambertz R., Leucht U., Schröder H.G., and Schmezer P. Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples. Environ. Mol. Mutagen. 24 (1994) 23-45
29. 1
30. Renwick A.G., Barlow S.M., Hertz-Picciotto I., Boobis A.R., Dybing E., Edler L., Eisenbrand G., Greig J.B., Kleiner J., Lambe J.D., Müller J.G., Smith M.R., Tritscher A., Tuijtelaars S., van den Brandt P.A., Walker R., and Kroes R. Risk characterisation of chemicals in food and diet. Food Chem. Toxicol. 41 (2003) 1211-1271
31. Sobels F.H. Evaluating the mutagenic potential of chemicals. The minimal battery and extrapolation problems. Arch. Toxicol. 46 (1980) 21-30
32. Spielmann H., Balls M., Dupuis J., Pape W.J., Pechovitch G., De Silva O., Holzhütter H.-G., Clothier R., Desolle P., Gerberick F., Liebsch M., Lovell W.W., Maurer T., Pfannenbecker U., Potthast J.M., Csato M., and Sladowski D. The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (Blind trial). Part 1. The 3T3 NRU phototoxicity test. Toxicol. In Vitro 12 (1998) 305-327
33. Treijtel N., van Helvoort H., Barendregt A., Blaauboer B.J., and van Eijkeren J.C.H. The use of sandwich-cultured rat hepatocytes to determine the intrinsic clearance of compounds with different extraction ratios: 7-ethoxycoumarin and warfarin. Drug Metab. Dispos. 33 (2005) 1325-1332
34. Van de Bovenkamp M., Groothuis G.M.M., Meijer D.K.F., and Olinga P. Liver fibrosis in vitro: Cell culture models and precision-cut liver slices. Toxicol. In Vitro 21 (2007) 545-557
35. Verwei M., van Burgsteden J.A., Krul C.A.M., van de Sandt J.J.M., and Freidig A.P. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. Toxicol. Lett. 165 (2006) 79-87
36. Vijverberg H.P., Oortgiesen M., Leinders T., and van Kleef R.G. Metal interactions with voltage- and receptor-activated ion channels. Environ. Health Perspect. 102 Suppl 3 (1994) 153-158
37. Walum E., Nordin M., Beckman M., and Odland L. Cellular methods for identification of neurotoxic chemicals and estimation of neurotoxicological risk. Toxicol. In Vitro 7 (1993) 321-326
38. Wortelboer H.M., deKruif C.A., van Iersel A.A.J., Falke H.E., Noordhoek J., and Blaauboer B.J. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. Biochem. Pharmacol. 42 (1991) 381-390
39. 1